ConductScience.org, home

Paper40430482

Norfloxacin Derivative with Carbazole at C-7 FQB-1 Induces Cytotoxic, Antiproliferative, and Antitumor Effects in an Experimental Lung Carcinoma Model.

Bocanegra-Zapata A and 9 others. Pharmaceuticals (Basel), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Norfloxacin Derivative with Carbazole at C-7 FQB-1 Induces Cytotoxic, Antiproliferative, and Antitumor Effects in an Experimental Lung Carcinoma Model. Papers, record 40430482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40430482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Norfloxacin Derivative with Carbazole at C-7 FQB-1 Induces Cytotoxic, Antiproliferative, and Antitumor Effects in an Experimental Lung Carcinoma Model.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-05-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bocanegra-Zapata AAlondrahttps://orcid.org/0009-0009-1612-6322
2Hernández-López HHiramhttps://orcid.org/0000-0002-4286-163X
3Leyva-Ramos SSocorrohttps://orcid.org/0000-0001-6303-3107
4Cervantes-Villagrana RDRodolfo Danielhttps://orcid.org/0000-0002-6599-7994
5Galván-Valencia MMarisolhttps://orcid.org/0000-0002-3640-5443
6Veyna-Hurtado LAL Angelhttps://orcid.org/0000-0003-0002-4419
7Tovar NGRNorma Guadalupe Ramírezhttps://orcid.org/0009-0002-8766-2607
8Albores-García DDamarishttps://orcid.org/0000-0003-3437-4791
9de la Torre JAFJuan Armando Floreshttps://orcid.org/0000-0002-4660-5641
10Cervantes-Villagrana ARAlberto Rafaelhttps://orcid.org/0000-0001-7344-353X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135633535Antiproliferative Activities of Lipophililic Fluoroquinolones- Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines.Asian Pac J Cancer Prev2022https://conductscience.org/library/papers/35633535PubMed
227976571[Fluoroquinolones: Non-antibacterial properties].Rev Esp Quimioter2017https://conductscience.org/library/papers/27976571PubMed
338756586Betaglycan sustains HGF/Met signaling in lung cancer and endothelial cells promoting cell migration and tumor growth.Heliyon2024https://conductscience.org/library/papers/38756586PubMed
428977631Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry.Nucleic Acids Res2017https://conductscience.org/library/papers/28977631PubMed
528667488Molecular docking studies on thirteen fluoroquinolines with human topoisomerase II a and b.In Silico Pharmacol2016https://conductscience.org/library/papers/28667488PubMed
634846393The modern role of boron as a 'magic element' in biomedical science: chemistry perspective.Chem Commun (Camb)2021https://conductscience.org/library/papers/34846393PubMed
729546541The Physiological Role of Boron on Health.Biol Trace Elem Res2018https://conductscience.org/library/papers/29546541PubMed
831803393Quinolone antibiotics.Medchemcomm2019https://conductscience.org/library/papers/31803393PubMed
939228758
Levofloxacin reposition-based design: synthesis, biological evaluation of new levofloxacin derivatives targeting topoisomerase II beta polymerase as promising anticancer agents, molecular docking, and physicochemical characterization.
RSC Adv2024https://conductscience.org/library/papers/39228758PubMed
1023495937New mechanistic and functional insights into DNA topoisomerases.Annu Rev Biochem2013https://conductscience.org/library/papers/23495937PubMed
1131487867Molecular Docking: Shifting Paradigms in Drug Discovery.Int J Mol Sci2019https://conductscience.org/library/papers/31487867PubMed
1228442170Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.Eur J Med Chem2017https://conductscience.org/library/papers/28442170PubMed
1328523239Cisplatin, Etoposide, and Irinotecan for Relapsed Small-Cell Lung Cancer.Transl Cancer Res2016https://conductscience.org/library/papers/28523239PubMed
1436914702Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis.Sci Rep2023https://conductscience.org/library/papers/36914702PubMed
1517348830Antitumor carbazoles.Anticancer Agents Med Chem2007https://conductscience.org/library/papers/17348830PubMed
1638613572Biological evaluation of levofloxacin and its thionated derivatives: antioxidant activity, aldehyde dehydrogenase enzyme inhibition, and cytotoxicity on A549 cell line.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38613572PubMed
1734463935Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.Pharm Res2021https://conductscience.org/library/papers/34463935PubMed
1830357526Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.Breast Cancer Res Treat2019https://conductscience.org/library/papers/30357526PubMed
1932516852Radiotherapy treatment for lung cancer: Current status and future directions.Respirology2020https://conductscience.org/library/papers/32516852PubMed
2026529666Trypan Blue Exclusion Test of Cell Viability.Curr Protoc Immunol2015https://conductscience.org/library/papers/26529666PubMed

See all 31 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40430482

GET https://conductscience.org/api/papers/v1/40430482/references?page=2